Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | OTC | P00480 | 1/20 | 0.34 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.34 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.34 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.34 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.34 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.34 |
| ▸ | NPY4R | P50391 | 4/20 | 0.34 |
| ▸ | NPY1R | P25929 | 3/20 | 0.34 |
| ▸ | NPY2R | P49146 | 2/20 | 0.34 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.33 |
| ▸ | ARG1 | P05089 | 1/20 | 0.33 |
| ▸ | CPB1 | P15086 | 1/20 | 0.33 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.33 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.33 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.32 |
| ▸ | TUBB | P07437 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Arginine SCHEMBL28491547 | 1.00 | GSR (0.42) | GSRMMP2OTCITGB3ITGA2B | |
| Arginine SCHEMBL14764665 | 1.00 | GSR (0.42) | GSRMMP2OTCITGB3ITGA2B | |
| Arginine SCHEMBL29263954 | 1.00 | GSR (0.42) | GSRMMP2OTCITGB3ITGA2B | |
| Arginine SCHEMBL1063567 | 1.00 | GSR (0.42) | GSRMMP2OTCITGB3ITGA2B | |
| Arginine SCHEMBL15525634 | 0.99 | GSR (0.41) | GSRMMP2OTCITGB3ITGA2B | |
| Arginine SCHEMBL20918548 | 0.96 | GSR (0.39) | GSRMMP2OTCITGB3ITGA2B | |
| Arginine SCHEMBL2337389 | 0.96 | GSR (0.39) | GSRMMP2OTCITGB3ITGA2B | |
| Arginine SCHEMBL25294109 | 0.95 | GSR (0.38) | GSRMMP2OTCITGB3ITGA2B | |
| Arginine SCHEMBL8314691 | 0.95 | GSR (0.38) | GSRMMP2OTCITGB3ITGA2B | |
| Arginine SCHEMBL1537331 | 0.95 | OTC (0.38) | OTCNPY4RNPY1RNPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 701 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-5328935-A | — | — | None | — | — | JP | disclosed |
| EP-4713004-A1 | TREATMENT OF A HEADACHE DISORDER WITH A BOTULINUM NEUROTOXIN A | Ipsen Biopharm Limited (GB) | 2026-03-25 | — | — | EP | disclosed |
| EP-4594341-A1 | CLOSTRIDIAL NEUROTOXINS COMPRISING AN ACTIVATING EXOGENOUS PROTEASE CLEAVAGE SITE | Ipsen Biopharm Limited (GB) | 2025-08-06 | — | — | EP | disclosed |
| EP-4593873-A1 | CLOSTRIDIAL NEUROTOXIN FOR USE IN A TREATMENT OF BLADDER PAIN SYNDROME | Ipsen Biopharm Limited (GB) | 2025-08-06 | — | — | EP | disclosed |
| EP-4587585-A1 | CELL-FREE CLOSTRIDIAL NEUROTOXIN ASSAYS | Ipsen Biopharm Limited (GB) | 2025-07-23 | — | — | EP | disclosed |
| WO-2025125793-A1 | FORMULATION | IPSEN BIOPHARM LIMITED (GB) | 2025-06-19 | — | — | WO | disclosed |
| WO-2025093844-A1 | USE OF CHIMERIC BOTULINUM TOXIN A FOR TREATING BLEPHAROSPASM AND HEMIFACIAL SPASM | IPSEN BIOPHARM LIMITED (GB) | 2025-05-08 | — | — | WO | disclosed |
| WO-2025093845-A1 | USE OF HIGH DOSE CHIMERIC BOTULINUM TOXIN A FOR THE TREATMENT OF UPPER FACIAL LINES | IPSEN BIOPHARM LIMITED (GB) | 2025-05-08 | — | — | WO | disclosed |
| EP-4514314-A1 | TREATMENT OF UPPER FACIAL LINES | Ipsen Biopharm Limited (GB) | 2025-03-05 | — | — | EP | disclosed |
| EP-4514378-A1 | TREATMENT OF CERVICAL DYSTONIA | Ipsen Biopharm Limited (GB) | 2025-03-05 | — | — | EP | disclosed |
| WO-1996017067-A1 | METHOD FOR SECRETING THROMBOPOIETIN POLYPEPTIDES | ZYMOGENETICS, INC. (US) | 1996-06-06 | — | — | WO | disclosed |
| WO-1996017062-A1 | LOW MOLECULAR WEIGHT THROMBOPOIETIN | ZYMOGENETICS, INC. (US) | 1996-06-06 | — | — | WO | disclosed |
| WO-1996011263-A1 | ENZYME FOR CLEAVAGE OF THE ANCHOR REGION OF SURFACE PROTEINS FROM GRAM POSITIVE BACTERIA | ROCKEFELLER UNIVERSITY (US) | 1996-04-18 | — | — | WO | disclosed |
| WO-1995030758-A1 | RECOMBINANT HK2 POLYPEPTIDE | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 1995-11-16 | — | — | WO | disclosed |
| WO-1995021920-A1 | HEMATOPOIETIC PROTEIN AND MATERIALS AND METHODS FOR MAKING IT | ZYMOGENETICS, INC. (US) | 1995-08-17 | — | — | WO | disclosed |
| WO-1995021626-A1 | METHODS FOR STIMULATING ERYTHROPOIESIS USING THROMBOPOIETIN | UNIVERSITY OF WASHINGTON (US) | 1995-08-17 | — | — | WO | disclosed |
| CN-1095481-A | Measure juvenile cell reagent | TOA MEDICAL ELECTRONICS (JP) | 1994-11-23 | — | — | CN | disclosed |
| CN-1089796-A | The infant strengthens series food and production method thereof | DIDUOLI FOOD CO LTD BEILIU COU (CN) | 1994-07-27 | — | — | CN | disclosed |
| JP-H05328935-A | FLAVOR IMPROVER | SB SHOKUHIN KK | 1993-12-14 | — | — | JP | disclosed |
| WO-1984003044-A1 | ENZYME INHIBITORS | FERRING AB (SE) | 1984-08-16 | — | — | WO | disclosed |